New Light-Based test could predict best treatment for leg artery disease
NCT ID NCT07313410
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to better understand how blood flow and oxygen use in the legs are affected in people with peripheral artery disease (PAD). Researchers will use a non-invasive device that shines near-infrared light on the leg to measure oxygen levels. The study will include 120 participants, both with and without PAD, and will track walking ability, quality of life, and treatment outcomes over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which treatments work best for individual patients with peripheral artery disease.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Cases- 80 individuals with PAD. Controls- 40 healthy volunteers, of similar age, sex, and ethnicity as the PAD cases.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cases, Aim 1 1. 18 or older 2. willing to participate under the conditions described in the informed consent form (ICF) 3. eligible to sign the ICF 4. established diagnosis of PAD confirmed by a physician 5. able to comply with the study requirements * Cases, Aim 2 1\) completed Aim 1 * Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease Exclusion Criteria: * Cases, Aim 1 1. Ankle-Brachial Index \>0.9 or \<0.4 2. isolated disease in aorta/iliac vessels 3. unstable angina or myocardial infarction in past 12 months 4. orthopedic or other physical limitations which would prevent data collection 5. contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator * Cases, Aim 2 1. unstable angina or myocardial infarction in past 12 months 2. orthopedic or other physical limitations which would prevent data collection 3. contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator). * Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP \>150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peripheral artery disease (PAD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Texas Arlington
NOT_YET_RECRUITINGArlington, Texas, 76019, United States
-
University of Texas at Arlington
RECRUITINGArlington, Texas, 76010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new scan predict who will struggle after leg artery surgery?
- Could a vitamin B3 pill boost walking ability in peripheral artery disease?
- Can a drop of blood predict disease years before it strikes?
- Rehab program shows promise in tracking blood flow recovery
- Can a scan predict amputation risk? new study aims to find out.
- Can a bone marrow stimulant help people with leg artery disease walk farther?